This work examines the chemical and physical effects of a material treatment process on the biopolymers PEEK, POM-h, POM-c, PTFE and UHMWPE. The polymers are analyzed physically and chemically using atomic force microscopy, profilometry, scanning electron microscopy, optical microscopy, contact angle measurement, FT infra-red spectroscopy and energy dispersive X-ray spectrometry. PEEK is found to be the most suitable polymer and FT Infra-red spectroscopy an informative analytic tool.

O objetivo da presente tese foi avaliar os efeitos da heparina de baixo peso molecular (HBPM) na perda óssea alveolar em ratos Wistar. Para a melhor compreensão e entendimento dos efeitos da HBPM se elaborou um único artigo com 40 ratos machos da linhagem Wistar de 60 dias de nascidos, os quais foram dívidos em 4 grupos experimentais previamente randomizados: Grupo Controle (C), Grupos Doença Periodontal (DP), Grupo Heparina (Hp) e Grupo Heparina+Doença Periodontal (Hp+DP) com um período experimental de 60 dias. Um animal foi perdido no período de aclimação, dois animais foram perdidos na primeira de três coletas sanguíneas pré-programadas e um rato foi perdido na colocação da ligadura. Os resultados observados foram analisados são perda óssea alveolar induzida onde houve diferença significava entre os grupos (C) e (DP), entre o grupo (C) e (Hp+DP), entre o grupo (DP) e (Hp) e o grupo (Hp) e (Hp+DP). Foi avaliado perda óssea alveolar não induzida onde não existiu diferença entre os grupos. Foi avaliado o peso do início ao final do período experimental. Foram avaliados o consumo de ração e agua onde não houve diferença significativa entre os grupos. Foram avaliados o número de megacariócitos nos fémures, onde também não existiram diferenças estatísticas. Foram avaliados números de adipócitos no timo, não havendo diferença significativa entre os grupos. Foram avaliados as plaquetas e desvio padrão onde não existiu diferença significativa entre os grupos. Foram avaliados os leucócitos e desvio padrão onde não houve diferença significativa entre os grupos. Posteriormente foi avaliado a porcentagem de linfócitos onde se achou diferença estatisticamente significativa na segunda coleta sanguínea entre o grupo (C) e grupo (Hp+DP) e grupo (Hp) e grupo (Hp+DP). Foi assim que as conclusões deste trabalho foram que o presente estudo mostrou que a HBPM não foi capaz de produzir perda óssea alveolar nos ratos Wistar, mas foi capaz de aumentar a quantidade de leucócitos e linfócitos, indicando a presença de um processo inflamatório. / In order to better understand and understand the effects of (LMWH), a single article was elaborated with 40 male rats of the 60 day old Wistar line, which were divided into four previously randomized experimental groups: Control Group (C), Groups Periodontal Disease (PD), Heparin Group (Hp) and Heparin Group + Periodontal Disease (Hp + PD) with an experimental period of 60 days. One animal was lost in the acclimation period, two animals were lost in the first of three preprogrammed blood collections and one mouse was lost in the ligation placement. The observed results were analyzed for induced alveolar bone loss where there was significant difference between groups (C) and (PD), between group (C) and (Hp + PD), between (PD) and (Hp) group and Group (Hp) and (Hp + PD). Uninduced alveolar bone loss was assessed where there was no difference between the groups. The weight of the onset at the end of the experimental period was evaluated. The ration and water consumption were evaluated where there was no significant difference between the groups. The number of megakaryocytes in the femurs was evaluated, in which there were also no statistical differences. Adipocyte numbers were evaluated in the thymus, with no significant difference between the groups. Platelets and standard deviation were evaluated where there was no significant difference between the groups. Leukocytes and standard deviation were evaluated where there was no significant difference between the groups. Later, the percentage of lymphocytes where a statistically significant difference was found in the second blood collection between group (C) and group (Hp + PD) and group (Hp) and group (Hp + PD) was evaluated. Thus the conclusions of this study were that the present study showed that LMWH was not able to produce alveolar bone loss in Wistar rats, but was able to increase the amount of leukocytes and lymphocytes, indicating the presence of a process inflammatory.

Introduction: Thrombotic events are among the most serious complications of sepsis and also the most frequent causes of morbidity and mortality in patients with sepsis. Currently, the administration of low molecular weight heparins (LMWH) is recommended in patients with severe sepsis for prophylaxis of these complications. However, this prophylaxis often fails. Objectives of the study: One of the objectives of our study was to examine changes in haemostasis in relation to the inflammatory response during 15 days of severe sepsis. The next objective was to determine whether a prophylactic inhibition of F Xa in the range from 0.2 to 0.4 IU/mL is achieved in these patients, if they receive the recommended prophylaxis with LMWH. We also recorded the dynamics of changes in the F Xa inhibition during the entire study period. Moreover, we tried to identify the factors that may affect the antithrombotic efficacy of the subcutaneously administered enoxaparin. Patient population and methods: A total of 35 ICU patients meeting the criteria of severe sepsis were enrolled in the study. Only 16 of these patients could be followed throughout the entire 15-day period. Patients were treated according to the current guidelines, including LMWH prophylaxis; enoxaparin (40 mg sc per day) was used in this study....

A esquistossomose é uma doença tropical negligenciada que atinge cerca de 200 milhões de pessoas em todo o mundo, abrangindo a América, a África, as Antilhas, o Oriente Médio e Próximo, além do Sudeste Asiático. A espécie encontrada no Brasil é a Schistosoma mansoni, onde se tem como tratamento típico a administração do Praziquantel ou da Oxamniquina. No entanto, sua característica de infecção se associa a saneamento básico precário e baixos padrões sócio-econômicos, de maneira que a reinfecção de doentes apresenta altas taxas de ocorrência, o que motiva a busca por fármacos ou vacinas antihelmíticas que superem esta dificuldade. Neste trabalho são utilizadas técnicas proteômicas para a identificação de proteínas que estejam potencialmente envolvidas na diferenciação entre os sexos, na interação entre parasitas de diferentes sexos ou com o hospedeiro. São estudadas preparações de amostras de sincício e vermes inteiros adultos machos e fêmeas por eletroforese bidimensional e frações de baixo peso molecular de sincício de vermes adultos machos e fêmeas por gel-LC. A expressão diferencial de proteínas de sincício investigada por gel-LC foi avaliada por análise estatítica, sendo detectadas 5 proteínas mais abundantes em machos e 2 em fêmeas, além de 6 proteínas identificadas somente em machos e 21 somente em fêmeas. Estas informações de expressão diferencial possibilitam a investigação dos recursos de sobrevivência e reprodução desenvolvidos evolutivamente por estes parasitas. / Schistosomiasis is a neglected tropical disease that affects approximately 200 million people around the world, occurring in America, Africa, the Antilles, Middle East and Near East, besides Southeast Asia. The species found in Brazil is Schistosoma mansoni, the typical treatment being administration of either Praziquantel or Oxamniquine. Although, the infection characteristics of this disease is associated with poor sanitation and hardened socio-economic conditions, resulting in high reinfection rates, which motivates the search for antihelmintic drugs and vaccines that overcome this situation. In this study proteomics techniques are used in the search of proteins potencially involved in the differentiation of individuals of both sexes, in the interactions between them and between the worms and the host. Samples of worm syncytium and adult whole worms of both male and female are studied by two-dimentional electrophoresis, while low molecular weight syncytium proteins from male and female adult worms were investigated by gel-LC. The differential protein expression in the syncytium investigated by gel-LC was analyzed statistically, being detected 5 proteins most abundant in males, and 2 in females, while 6 were identified solely on males and 21 on females. The information concerning protein differential expression allows the investigation of survival strategies developed evolutionarily by these parasites.

Orientador: Liliane Maria Ferrareso Lona / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Engenharia Química / Made available in DSpace on 2018-08-19T13:42:42Z (GMT). No. of bitstreams: 1 ChaparroMontezuma_GermanGiovanny_M.pdf: 3877380 bytes, checksum: 8f8924d77c55a7ec361451caa074630e (MD5) Previous issue date: 2011 / Resumo: A Polimerização radicalar mediada por nitróxido (NMRP) é uma técnica da polimerização controlada com a habilidade de produzir polímeros com um alto controle da sua microestrutura, estreita distribuição de massa molar e baixos valores de polidispersidade (muito próximos a um). As características do polímero obtidas na polimerização controlada têm aumentado o interesse de levar essa técnica para um nível industrial, no entanto a polimerização controlada ainda apresenta desafios como, por exemplo, desenvolver com sucesso a NMRP em emulsão, a baixas temperaturas e usando nitróxidos de baixo custo e disponíveis comercialmente, como 2,2,6,6-tetrametil-1-piperidiniloxi (TEMPO). A NMRP em emulsão de estireno a temperaturas inferiores a 100 ° C foi realizada com sucesso neste trabalho. TEMPO foi utilizado como agente controlador ainda que este nitróxido normalmente opere a temperaturas acima de 120 °C, sendo demonstrado o controle da massa molar e da polidispersidade, juntamente com uma rápida taxa de polimerização em um sistema de emulsão / Abstract: Nitroxide-mediated radical polymerization (NMRP) is a controlled polymerization technique with the ability to produce polymers with a highly controlled microstructure, narrow molecular weight distribution and low polydispersity values (very close to one). The polymer characteristics obtained in controlled radical polymerization have increased the interest of bringing this technique to an industrial level, however there are still some challenges to be faced, like, successfully develop NMRP in emulsion at low temperatures (lower than 100 °C) with inexpensive nitroxides commercially available, as 2,2,6,6- tetramethyl-1-piperidinyloxy (TEMPO). In this work NMRP of styrene in emulsion at temperatures below to 100 °C was carried out successfully. TEMPO was used as controller agent although this nitroxide usually works at temperatures above 120 °C. It was demonstrated an optimal control of molecular weights and polydispersities, together with a fast polymerization rate in an emulsion system / Mestrado / Desenvolvimento de Processos Químicos / Mestre em Engenharia Química

Doctor of Philosophy / Department of Grain Science and Industry / Finlay I. MacRitchie / Novel genetic materials were used to deduce gluten protein composition-functionality relationships. The Pegaso bread wheat near-isogenic lines (NILs) included addition, variation and/or deletion of major loci coding for HMW-GS, LMW-GS and gliadins. The waxy wheat lines (Svevo and N11 set) included wild, partial and complete waxy lines. Triticale translocations include 1R.1D and 1A.1D lines (GDS7, Trim, Rhino and Rigel sets) with HMW-GS 5+10 and 2+12. The main goal of the study was to establish the usefulness of NILs as appropriate materials to investigate the structure-function relationships of wheat proteins and to evaluate the performance of unique triticale translocations and waxy wheat lines. Effect of genetic variation on phytochemical (phenolic acid and policosanol) contents was also studied. Innovative methods like MALLS, Lab-on-a-chip and micro (10 g) baking were utilized along with traditional analytical methods. Results confirmed the potential of using NILs in understanding the effects of certain proteins coded at specific loci that might often be targeted in breeding programs. Removal of expected chain terminators at Gli-1/Gli-2 loci causes a shift in MWD to higher values, reflected in higher UPP and dough strength. Lines with HMW-GS 5+10 were clearly separated from 2+12 lines in terms of dough strength and UPP. The present study obtained evidence that modified ω-gliadins acts as chain terminators and cause reduction of protein polymer size and thus shifts in MWD. Marked differences in terms of milling characteristics, protein composition and ultimately in end-use functionality were observed with various waxy wheat null lines. Loaf volumes with waxy wheat flour alone were higher than a 50% blend with commercial wheat; however, breads were unacceptable to consumers in all aspects. Poor milling quality, very low mixing times with low bread loaf volumes were typical of all the triticales studied. However, translocation of the HMW-GS from wheat chromosome 1D increased dough strength, particularly the HMW-GS 5+10. Among the phytochemicals studied, double nulls at Gli-1 loci of Pegaso NILs had the highest total policosanols and total phenolic acid contents.Slight variation to wheat phenolic acid composition and contents were observed with waxy wheat and triticale lines.

Background: The risk of ischaemic stroke in patients with atrial fibrillation (AF) and mechanical heart valve (MHV) prostheses can be reduced by oral anticoagulation (OAC), which increases the risk of serious bleeding. The aims of this thesis were [1] to find out how effective and safe warfarin is where treatment quality is high, i.e. Sweden, with proportion of time that patients spend within the therapeutic range (TTR) &gt;70%, [2] whether there is evidence for administering low-molecular-weight heparin (LMWH) during temporary interruptions of OAC (bridging therapy), and whether non-vitamin K-dependent oral anticoagulants (NOACs) as a group, [3] or individually, [4] are more effective and safer than warfarin when used for stroke prevention in patients with AF. Materials and methods: All four studies were retrospective, based on the Swedish anticoagulation register Auricula, and done with merging of data from some or all of the National Patient Register, the Prescribed Drug Register, the Swedish Stroke Register (Riksstroke), and the Cause of Death Register. In studies 2–4, propensity score matching was performed to obtain treatment groups with similar risk profiles. Outcomes were defined as haemorrhages or thromboses requiring specialist care, or death. Haemorrhages were intracranial, gastrointestinal, or other. Thromboses were ischaemic stroke, systemic embolism, myocardial infarction, or venous thromboembolism (VTE). Study 1 described all patients on warfarin during 2006–2011, which was before the introduction of NOACs. Study 2 was a cohort study of all patients who had a planned interruption of warfarin during the same period. Study 3 included all 49,011 patients starting OAC for stroke prevention due to AF between 1 July 2011 and 31 December 2014, and study 4 all 64,382 patients with the same indication between 1 January 2013 and 31 December 2015. Results: Study 1 showed that for the 77,423 patients on warfarin with 217,804 treatment years, TTR was 77.4% for patients with AF, 74.5% with MHV, and 75.9% with VTE. Annual rates of intracranial bleeding were 0.38%, 0.51%, and 0.30%. In study 2, with 14,556 warfarin interruptions, the 30-day risk of a bleeding requiring specialist care was 0.64% for LMWH treated and 0.46% for controls. For patients with VTE as indication for OAC, bleeding rate with LMWH was significantly higher at 0.85% vs. 0.16% (hazard ratio 5.24, 95% confidence interval 1.39–19.77), but with no difference for patients with MHV or AF. The incidence of ischaemic complications was higher in the LMWH bridging group overall and for patients with MHV and AF, but not for patients with VTE. In study 3, for the 12,694 patients starting NOAC (10,392 treatment years) or matched warfarin patients (9,835 treatment years, TTR 70%) due to AF, annual incidence of ischaemic stroke and systemic embolism did not differ between the groups (1.35% vs. 1.58%), but risks of major bleedings and intracranial bleedings were significantly lower: 2.76% vs. 3.61% and 0.40% vs. 0.69%. In study 4, patients on individual NOACs (6,574 dabigatran, 8,323 rivaroxaban, 12,311 apixaban) were compared to 37,174 patients starting warfarin (in total 81,176 treatment years). No NOAC showed any difference in risk of ischaemic stroke or systemic embolism, but there were fewer intracranial bleedings, serious bleedings overall, and deaths for dabigatran and apixaban compared to warfarin. For patients starting rivaroxaban the risk of gastrointestinal bleeding was higher than for matched warfarin counterparts, with no significant differences in other bleeding risks, or mortality. Conclusions: Swedish warfarin treatment shows TTR levels that are high by international standards, correlating to low incidences of ischaemic and haemorrhagic events. LMWH bridging has not been proven beneficial, even for patients with MHV, meaning that bridging in general cannot be recommended. NOACs as a group were safer than high-quality warfarin treatment. Efficacy did not differ, even when comparing individual NOACs to warfarin, but there were fewer bleedings on dabigatran and apixaban. Although not more efficient than warfarin with a high TTR, NOACs should be the recommended first choice for OAC in AF, on the merit of lower bleeding risks. / <p>Finansiär: Forskning och Utveckling, Region Västernorrland</p>

Ce travail se proposait de développer, à l’échelle du laboratoire, un procédé de production microbienne d’acide hyaluronique (AH), biopolymère d’intérêt pour la cosmétique et la santé, chez une bactérie lactique naturellement productrice, Streptococcus zooepidemicus. Une étude bibliographique a permis d’identifier les points potentiellement critiques pour ce travail qui sont la composition du milieu de culture (identification de nutriments essentiels à la synthèse d’acide hyaluronique), les conditions opératoires et plus particulièrement d’oxygénation (transfert d’oxygène mais aussi maintien du potentiel d’oxydo-réduction), en relation avec les performances de production et le métabolisme des souches considérées. Une étape préliminaire a consisté en un développement et une amélioration de techniques analytiques pour disposer d’outils pertinents de suivi du métabolisme de Streptococcus zooepidemicus. La quantification de la biomasse hors acide hyaluronique ainsi que la détection de l’activité hyaluronidasique ont ainsi été développées tandis que d’autres méthodes chromatographiques et enzymatiques ont été simplement appliquées et validées aux substrats et métabolites considérés. La mise en œuvre de souches « environnementales » prélevées sur des sites infectieux chez le cheval, ainsi que de souches de collection, a permis dans un premier temps de formuler un milieu de culture et de définir des conditions de mise en œuvre exploitables à plus grande échelle pour la production d’AH. Des résultats très encourageants ont pu être obtenus avec des productions d’AH supérieures aux essais de la littérature, tout en mettant en avant des facteurs influents cruciaux tels que la concentration initiale en glucose ou encore l’oxygénation des cultures. L’influence de ces facteurs a été étudiée par la suite par le biais de cultures en bioréacteur de laboratoire en modes discontinu et discontinu-alimenté avec pour résultat l’obtention d’un mode de mise en œuvre et de conditions physico-chimiques de production améliorées. En parallèle, une étape importante de ce travail a consisté en une approche d’amélioration de souches « environnementales » par mutagénèse aléatoire, les performances de ces souches s’avérant initialement décevantes. Des mutants surproducteurs ont ainsi été générés, caractérisés au niveau de leurs performances métaboliques et conservés. En dernier lieu, un des mutants les plus performant a été mis en œuvre dans les conditions et le mode de culture sélectionnés précédemment. Tant le niveau de production d’AH, la productivité associée, que les tailles obtenues ont permis de valider ce travail de développement d’un procédé microbien de production d’AH, tout en identifiant de nouvelles voies d’amélioration / This work intended to develop a laboratory scaleproduction process ofhyaluronic acid (HA), a biopolymer of health and cosmetic interest, using a naturally AH producing lactic acid bacterium, Streptococcus zooepidemicus. A literature review allowed to identify the following critical points: firstly, the composition of the culture medium (identification of essential nutrients for microbial growth and synthesis of HA), secondly, the oxygenation level (oxygen transfer and associated redox modifications), and finally, in relation with, the production and metabolism abilities of the considered strains. A preliminary step was dedicated to the developmentorthe improvementof analytical techniques in order todispose of appropriate tools for the monitoring of Streptococcus zooepidemicus metabolism. The quantification of the biomass without considering capsular HA fraction as well as detection of hyaluronidase activity have been developed while other chromatographic and enzymatic methods have been more basically applied to and validated with the substrates and metabolites considered. The laboratory scale cultures of collection (ATCC) as well as “environmental” strains were initially used to formulate a workable cultivation broth and to define suitable culture conditionsfor a use at a larger scale to produce HA. Very positive results were obtained with higher production of HA in comparison with literature assays, while critical influencing factors such as the initial glucose concentration or the oxygenation levelin cultures were highlighted. The influence of these factors was thoroughly studied with bioreactor cultures in both batch and fed-batch modes leading to improved cultivation conditions and culture mode. In parallel, another important step consisted in the highly performance improvement of initially low HA producing "environmental" strains via random mutagenesis. Very promising overproducing mutants have therefore been generated, characterized in their kinetic and metabolic capabilities and long-term stored. At last, one of the best and most reliable mutant has been cultivated with the best previously selected medium composition and operating conditions. Both the HA production level, productivity and size observed validated the findings of this process development work, while helping to identify new improvement domains and strategies

Anticoagulants, also known as antithrombotics, are among the most commonly prescribed medications in the United States. Understanding how these medications work, the propensity for interactions with other drugs, dietary factors, and disease states is important for clinicians assessing and providing care to patients in all environments. In this review, we seek to provide essential information for the home health care provider for evaluating patients receiving anticoagulants commonly prescribed in the home health care setting. The low-molecular-weight heparins and vitamin K antagonists are the most commonly used agents for outpatient anticoagulation. New agents, such as the direct factor Xa inhibitors and direct thrombin inhibitors have recently been approved with additional new agents in the approval process and development pipeline. We seek to review the most pertinent information for each of these classes of medications providing information on pharmacology, interactions with other drugs, diet, and diseases and important clinical information.

Discovery of Novel Serum Biomarkers for Diagnosing and Staging Alzheimer’s DiseaseDipti Jigar ShahDepartment of Chemistry and Biochemistry, BYUDoctor of PhilosophyAlzheimer’s disease (AD) is an untreatable neurologic disease affecting more than 5 million Americans, most over 60 years of age. Protein plaques and neurofibrillary tangles typify AD brain pathology and are thought to cause the progressive dementia and brain shrinkage observed in AD. Currently there are no methods to diagnose the disease at a time before damage becomes irreversible.Biochemical tests for AD using cerebrospinal fluid analysis or neuroimaging are not yet sufficiently sensitive and specific, and they are invasive. This points to a need for a more easily applied and more sensitive diagnostic test. Although the gross anatomical changes are localized to the brain, AD is likely to involve changes throughout the body. As a result of this, changes in the abundance of certain biomolecules present in the circulation system are likely to occur. Consequently, a serum proteomics approach able to measure such changes, when applied to AD, would likely find quantitative changes in relevant molecules that can help diagnose the disease correctly, ideally early in the disease process. The goal of this work was to discover and validate novel diagnostic serum biomarkers for AD. For biomarker discovery and validation, we used a novel serum proteomics approach involving reversed phase capillary-liquid chromatography-electrospray ionization-quadrupole-time of flight mass spectrometry. Our samples were protein depleted, which helped us survey low molecular weight species in the serum without ion suppression from larger proteins like albumin. We were able to observe more than 8000 molecular species in a single run. The overall project was comprised of four studies: (i) discovery of novel potential serum AD markers, (ii) blinded validation of diagnostically promising biomarkers found in the initial study, with their further chemical identification, (iii) exploring gender-based serum AD biomarkers, and (v) discovery of biomarkers that distinguish early versus moderate stage AD. In the first study, the approach found 38 significant (p < 0.05) biomarkers and 21 near significant (p = 0.05 to 0.099) biomarkers. On using the forward selection approach, we built multi-marker panels with specificities and sensitivities higher than 80%.The second study reports on a blinded validation study that was performed on a new set of serum samples. We focused on the 13 most promising AD biomarkers found as part of the initial study. We successfully validated 4 of these biomarkers that showed highly significant statistical p-values. As part of this study, research was conducted to identify these 4 biomarkers, which was accomplished using tandem mass spectrometry with fragmentation experiments. The third study used data from the initial study but looked at gender specific biomarkers. We found 31 significant and near significant serum AD biomarkers for women, 16 for men, and 25 that were gender independent. Multi-marker panels of AD biomarkers for women or men had sensitivities of >60% and specificities >85%.In the fourth study, cases with moderate AD were compared to cases with very mild or mild AD to find novel biomarkers that could be used for staging. We found 44 significant and near significant biomarkers that were quantitatively different between mild and severe AD. In conclusion, we were successful in accomplishing the goal of this work of finding, validating and identifying novel serum biomarkers that diagnose AD.